Literature DB >> 3143576

Clinical efficacy of ciprofloxacin versus doxycycline in the treatment of non-gonococcal urethritis in males.

A H van der Willigen1, A A Polak-Vogelzang, L Habbema, J H Wagenvoort.   

Abstract

In a randomised study the clinical efficacy of ciprofloxacin was compared with that of doxycycline administered in two different dosage schemes to male patients suffering from non-gonococcal urethritis. Fourteen days after completion of therapy (day 21) pyuria was absent in 30 of 100 patients in the ciprofloxacin group; Chlamydia trachomatis was isolated from five and Ureaplasma urealyticum from eight patients. In the 100 mg doxycycline group (n = 60) pyuria was absent in 36 patients (60%) and Ureaplasma urealyticum was isolated from six patients on day 21. In the 200 mg doxycycline group (n = 45) pyuria was absent in 18 patients (40%) and Ureaplasma urealyticum was isolated from two patients on day 21. Side-effects were mild and transient in all groups. It is concluded that ciprofloxacin given in a dosage of 1 g for seven days is not effective in the treatment of non-gonococcal urethritis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3143576     DOI: 10.1007/bf01964246

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

1.  Infection with Mycoplasma pneumoniae in civilians in the Netherlands.

Authors:  J F Hers; N Masurel
Journal:  Ann N Y Acad Sci       Date:  1967-07-28       Impact factor: 5.691

2.  Treatment of nongonococcal urethritis with ciprofloxacin.

Authors:  I W Fong; W Linton; M Simbul; R Thorup; B McLaughlin; V Rahm; P A Quinn
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

3.  One-week treatment of chlamydia-positive urethritis with doxycycline and tetracycline chloride in males.

Authors:  T Juvakoski; J Lauharanta; L Kanerva; A Lassus
Journal:  Acta Derm Venereol       Date:  1981       Impact factor: 4.437

4.  Quinolones in the treatment of gonorrhoea and Chlamydia trachomatis infections.

Authors:  E Stolz; M J Tegelberg-Stassen; A H Van der Willigen; J C Van der Hoek; T Van Joost; L Mooi; J H Wagenvoort
Journal:  Pharm Weekbl Sci       Date:  1986-02-21

5.  Evaluation of roxithromycin in the treatment of non-gonococcal urethritis in males.

Authors:  A H van der Willigen; K H Tjiam; J H Wagenvoort; A A Polak-Vogelzang; M F Michel; E Stolz
Journal:  Eur J Clin Microbiol       Date:  1986-12       Impact factor: 3.267

6.  Detection of Chlamydia trachomatis inclusions in Mccoy cell cultures with fluorescein-conjugated monoclonal antibodies.

Authors:  W E Stamm; M Tam; M Koester; L Cles
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

7.  Tetracycline in nongonococcal urethritis. Comparison of 2 g and 1 g daily for seven days.

Authors:  W R Bowie; J S Yu; A Fawcett; H D Jones
Journal:  Br J Vener Dis       Date:  1980-10

8.  Urease color test medium U-9 for the detection and identification of "T" mycoplasms in clinical material.

Authors:  M C Shepard; C D Lunceford
Journal:  Appl Microbiol       Date:  1970-10

9.  Evaluation of ciprofloxacin 500 mg twice daily for one week in treating uncomplicated gonococcal chlamydial, and non-specific urethritis in men.

Authors:  O P Arya; D Hobson; C A Hart; C Bartzokas; B C Pratt
Journal:  Genitourin Med       Date:  1986-06

10.  Treatment of uncomplicated gonococcal urethritis in men with two dosages of ciprofloxacin.

Authors:  M J Tegelberg-Stassen; J C van der Hoek; L Mooi; J H Wagenvoort; T van Joost; M F Michel; E Stolz
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

View more
  3 in total

1.  Antimicrobial susceptibility and serotyping of Chlamydia trachomatis strains isolated before and after treatment with ciprofloxacin and doxycycline.

Authors:  A H van der Willigen; T van Rijsoord-Vos; J H Wagenvoort; W E Stamm; R J Suchland; E Stolz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

Review 2.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

3.  Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro.

Authors:  U Dreses-Werringloer; I Padubrin; B Jürgens-Saathoff; A P Hudson; H Zeidler; L Köhler
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.